PharmaLectures.com

Courses › Pharma training by country › Same molecule, different rulebook: Egyptian, Gulf and MENA regulation versus the EU

Same molecule, different rulebook: Egyptian, Gulf and MENA regulation versus the EU

Stop rebuilding European dossiers from scratch for Egypt and the Gulf.

  • 8 audio modulesthree lengths each
  • 1 h 20 min to 6 h 40 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Egypt, Gulf and MENA companieswho it is written for

Why this training matters

Your team sends the Saudi Food and Drug Authority a copy of the European dossier. The reviewer raises a deficiency on the stability data and the file stops moving. The launch date slips while your team rebuilds the file and sales waits for an answer.

What changes after this course

Your regulatory staff check each European file against local rules before it leaves the building. They file dossiers that give the reviewer less to query. You hold a certificate for every learner, a recorded questionnaire per module and a training record per person.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your regulatory team stops guessing which parts of the European dossier carry over. Modules 2 to 5 of the Common Technical Document stay common, and Module 1 gets the local administrative data the Saudi Food and Drug Authority and the Egyptian Drug Authority look for. The gap is closed before the reviewer writes a deficiency letter.

Quality managers line up Module 3 data and EudraLex Volume 4 practice with what the Saudi Food and Drug Authority expects at inspection. The site master file follows the Pharmaceutical Inspection Co-operation Scheme format and carries the extra items the authority asks for. Clinical leads decide on the spot whether International Council for Harmonisation E5 points to a local bridging study.

Leaflets and packs go to review with fewer open points. The leaflet respects Directive 2001/83/EC and carries Arabic where the market asks for it, and the pack shows the local representative. Pharmacovigilance staff know which timeline applies to each periodic safety update report and which Oman Ministry of Health route to use.

Site directors face an Egyptian Drug Authority pre-approval inspection with the quality management system procedures ready, and a straight answer when the inspector spots a gap against European records. Regulatory affairs managers prepare biological product, biosimilar and United Arab Emirates medical device files without waiting for an outside consultant to read the rules for them.

Who needs this training

  • Regulatory Affairs Manager

    You sit down to file with the Saudi Food and Drug Authority and see that the European Module 1 template lacks the local administrative data. You know what to add before you submit.

  • Quality Assurance Director

    An Egyptian Drug Authority inspector arrives for a pre-approval inspection and asks for a site master file in the regional format. You hand it over, complete, and answer the follow-up questions.

  • Clinical Development Lead

    You review a development plan for a drug that may be ethnically sensitive and must decide whether to fund a local bridging study before filing in the Gulf. You make the call with a reason you can defend.

  • Pharmacovigilance Specialist

    An adverse event triggers a report. You find the right Oman Ministry of Health route and file within the timeline that applies, with the data the form asks for.

  • Packaging and Artwork Coordinator

    Artwork approved in Europe arrives with no space for Arabic text or the local representative. You catch it before print, not after the boxes are made.

Roles: Regulatory affairs, Quality assurance and Qualified Person

Businesses: every kind of pharma company

Countries: Egypt, Gulf and MENA

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Build a Common Technical Document dossier whose Module 1 meets the administrative checks of a Gulf Cooperation Council authority.
  2. Write a site master file in the Pharmaceutical Inspection Co-operation Scheme format and add the items the Saudi Food and Drug Authority requests.
  3. Decide, using International Council for Harmonisation E5, whether a product needs a local bridging study before you file.
  4. Add the local representative details and Arabic text to a patient leaflet that already follows Directive 2001/83/EC.
  5. Set the due dates for periodic safety update reports in each country where you hold a registration.
  6. Present your quality management system procedures to an Egyptian Drug Authority inspector in an order that answers their questions.
  7. Check a dossier against the submission format requirements of the authority you are filing with.

What the company gets

  • Your dossiers reach the reviewer with the local administrative data in place, so fewer deficiency letters stop your launch.
  • Your site has a site master file and quality management system procedures ready for the inspector, in the format the authority expects.
  • Your packs and leaflets carry Arabic text and local representative details before print, so they do not go back for reprint.
  • Your pharmacovigilance team holds the reporting route and timeline for each market, so no report is late because someone went looking for the form.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 8 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h 20 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard3 h 20 min25 min a module, for regulatory, quality and business-development staff
Expanded6 h 40 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Regulatory affairsStandard3 h 20 min
Quality assurance and Qualified PersonStandard3 h 20 min

Course outline: 8 modules

8 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Map which regulator decides what in Europe, Egypt and the Gulf before you file

    • Why a European Medicines Agency approval does not open the door in Egypt or the Gulf, and what does.
    • When to use the Gulf Cooperation Council Centralized Registration route and when to file nationally.
    • What the Egyptian Drug Authority does with your file after receipt, so you know when to chase.
  2. 2Build one Common Technical Document dossier that fits both regions

    • How to keep Modules 2 to 5 stable and rewrite only Module 1 for each authority.
    • What to do when an authority accepts paper or hybrid files and your team only builds electronic ones.
    • Where a Common European Submission Portal upload and a local hybrid submission part ways.
  3. 3Adapt Quality Module 3 data to regional Good Manufacturing Practice

    • Where EudraLex Volume 4 and Saudi Food and Drug Authority expectations differ in your Module 3 data.
    • How to write a site master file to the Pharmaceutical Inspection Co-operation Scheme format.
    • What to do when the authority asks for a site master file item your European version never carried.
  4. 4Decide when local bridging is needed for non-clinical and clinical data

    • When European data stands as it is and when a Middle Eastern authority wants local data.
    • How to apply International Council for Harmonisation E5 on ethnic factors to decide on a bridging study.
    • What to do when your pivotal trials ran outside the region and the reviewer asks why they apply here.
  5. 5Draft packaging and leaflets that pass local review, Arabic included

    • Where Directive 2001/83/EC leaflet rules and Gulf or Middle Eastern leaflet rules part ways.
    • What to do when the market requires Arabic on the pack and the leaflet and your artwork has no room.
    • The local representative details that belong on the pack, so a missing line does not send boxes back.
  6. 6Schedule post-market activities and adverse event reports on time

    • How to map European Good Pharmacovigilance Practices onto Oman Ministry of Health requirements.
    • Where to find the timeline for periodic safety update reports in each country you sell in.
    • What to do when a local adverse drug reaction form asks for data your system does not hold.
  7. 7Pass Egyptian and European inspections with the right file in hand

    • How to prepare for an Egyptian Drug Authority pre-approval inspection at your own site.
    • Which quality management system procedures to have on the table when the inspector sits down.
    • What to say when the inspector finds a gap between your European and local compliance records.
  8. 8Clear special product categories and prepare for electronic submission

    • How the pathway for biological products and biosimilars differs from a small-molecule filing.
    • What the United Arab Emirates Ministry of Health and Prevention expects in a medical device application.
    • What to change in your dossiers now so the move to electronic submission finds you ready.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

8 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h 20 min in the briefing length and 6 h 40 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Egypt, Gulf and MENA companies. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 72 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team